Evaluate EGFR Mutation Status and Impact Factors in North China
Completed
- Conditions
- Non-Small Cell Lung Cancer
- Interventions
- Other: Non interventional study
- Registration Number
- NCT02620657
- Lead Sponsor
- ying cheng
- Brief Summary
Approximately 3000 advanced NSCLC patients, who fulfil the inclusion/exclusion criteria, will be recruited by 30 sites in North China.
- Detailed Description
Approximately 3000 advanced NSCLC patients will be recruited , and the medical information of recruited patients must be recorded in the hospital electronic system from Jan 1st 2014 to Dec 31st 2014 .The study will focus on the EGFR testing rate in adenocarcinoma patients，so the collecting data for non-adenocarcinoma patients will be controlled in less than 10% for each site.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 2809
Inclusion Criteria
- Histological or cytological confirmed NSCLC;
- Patients were diagnosed with advanced NSCLC from Jan 1st 2014 to Dec 31st 2014;
- Researchers should collect the records of consecutive NSCLC patients in each site.
Exclusion Criteria
- Any patients without NSCLC diagnosis;
- Any patients which were diagnosed with advanced NSCLC before Jan 1st 2014 or after Dec 31st 2014.
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Non interventional study Non interventional study The patients with advanced NSCLC who have the medical records from Jan 1st 2014 to Dec 31st 2014 will be recruited .
- Primary Outcome Measures
Name Time Method To investigate the proportion of advanced NSCLC patients who performed EGFR mutation test 2014.01.01-2014.12.31
- Secondary Outcome Measures
Name Time Method